SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-009837
Filing Date
2023-03-30
Accepted
2023-03-30 17:14:43
Documents
13
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36191
2 ex99-1.htm EX-99.1 82475
  Complete submission text file 0001493152-23-009837.txt   306107

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vvos-20230330.xsd EX-101.SCH 3218
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vvos-20230330_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vvos-20230330_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3724
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 23781747
SIC: 3841 Surgical & Medical Instruments & Apparatus